Young Chan Kim

I obtained a BSc degree in Biochemistry from Imperial College London and completed my medical degrees (BMBS, BMedSci and MRes) from the University of Nottingham. I then spent few years working in junior doctor posts before coming to Oxford to start a DPhil in Clinical Medicine.

My DPhil studies focused on vaccine development against arthropod-borne viruses supported by Innovate UK funding. I was awarded highly prestigious NDM Graduate Student Prize 2020 (Overall Prize Winner) for my overall performance during my DPhil at the Nuffield Department of Medicine (NDM).

In 2021, I received an NIHR Oxford BRC grant for my postdoctoral research and I was elected as a JRF Fellow at Wolfson College. I joined the Oxford Vaccine Group (OVG) as a Senior Postdoctoral Researcher in 2021 to lead the projects on enteric fever (typhoid and paratyphoid) and Q-fever.

In 2022, I was awarded the Sir Henry Wellcome Fellowship to start my independent research on development of vaccines and therapeutics against arboviruses. Between 2022-2023, I received MRC HIC-VAC and MRC IAA grants to develop serological assays against enteric fever, as well as the MLSTF and MRC IAA grants to develop a novel vaccine against Chagas disease.

After successfully securing three SRBI Innovate UK awards in 2023, I am now leading a group of postdocs, research assistants and DPhil students to develop new vaccines against Plague, Q fever, alphaviruses and the human challenge studies under the direction of Prof Sir Andrew Pollard. I was elected as a RF Fellow at Wolfson College in 2023.

Currently I am a Sir Henry Wellcome Fellow, a Principal Investigator (PI) at OVG, RF Fellow at Wolfson College, Lecturer in Medicine at Somerville College, and Medical Doctor in Internal Medicine at the Oxford University Hospitals NHS Trust.